引用本文: | 何友兼, 董秋美. 贝伐单抗一线治疗结直肠癌进展后二线应用的临床生存获益:来自于BRiTE的研究[J]. 循证医学, 2009, 9(3): 150-151. DOI: 10.3969/j.issn.1671-5144.2009.03.017 |
Citation: | HE You-jian, DONG Qiu-mei. Clinical Overall Survival Benefit of Bevacizumab beyond First Progression in Colorectal Cancer: From BRiTE Study[J]. Journal of Evidence-Based Medicine, 2009, 9(3): 150-151. DOI: 10.3969/j.issn.1671-5144.2009.03.017 |